MacroGenics Announces Date of First Quarter 2019 Financial Results Conference Call
April 24, 2019 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, April 24, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
MacroGenics Reports Presentation of Data at the AACR Annual Meeting 2019
April 03, 2019 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, April 03, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
MacroGenics to Participate in Upcoming Investor Conferences
April 02, 2019 17:00 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, April 02, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...